☰

Matthew E. Butchbach, Ph.D. - Publications

Affiliations: 
2003 Ohio State University, Columbus, Columbus, OH 
Area:
Biochemistry, Neuroscience Biology, Molecular Biology, Cell Biology
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Edwards JD, Butchbach ME. Effect of the Butyrate Prodrug Pivaloyloxymethyl Butyrate (AN9) on a Mouse Model for Spinal Muscular Atrophy. Journal of Neuromuscular Diseases. 3: 511-515. PMID 27911337 DOI: 10.3233/JND-160187  0.303
2016 Rossi SL, Lumpkin CJ, Harris AW, Holbrook J, Gentillon C, McCahan SM, Wang W, Butchbach ME. Identification of early gene expression changes in primary cultured neurons treated with topoisomerase I poisons. Biochemical and Biophysical Research Communications. PMID 27641670 DOI: 10.1016/j.bbrc.2016.09.068  0.362
2016 Butchbach ME, Lumpkin CJ, Harris AW, Saieva L, Edwards JD, Workman E, Simard LR, Pellizzoni L, Burghes AH. Protective effects of butyrate-based compounds on a mouse model for spinal muscular atrophy. Experimental Neurology. PMID 26892876 DOI: 10.1016/J.Expneurol.2016.02.009  0.323
2015 Harris AW, Butchbach ME. The effect of the DcpS inhibitor D156844 on the protective action of follistatin in mice with spinal muscular atrophy. Neuromuscular Disorders : Nmd. 25: 699-705. PMID 26055638 DOI: 10.1016/j.nmd.2015.05.008  0.302
2014 Mack SG, Cook DJ, Dhurjati P, Butchbach ME. Systems biology investigation of cAMP modulation to increase SMN levels for the treatment of spinal muscular atrophy. Plos One. 9: e115473. PMID 25514431 DOI: 10.1371/Journal.Pone.0115473  0.315
2014 Maeda M, Harris AW, Kingham BF, Lumpkin CJ, Opdenaker LM, McCahan SM, Wang W, Butchbach ME. Transcriptome profiling of spinal muscular atrophy motor neurons derived from mouse embryonic stem cells. Plos One. 9: e106818. PMID 25191843 DOI: 10.1371/Journal.Pone.0106818  0.352
2010 Butchbach ME, Singh J, Thorsteinsdóttir M, Saieva L, Slominski E, Thurmond J, Andrésson T, Zhang J, Edwards JD, Simard LR, Pellizzoni L, Jarecki J, Burghes AH, Gurney ME. Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy. Human Molecular Genetics. 19: 454-67. PMID 19897588 DOI: 10.1093/Hmg/Ddp510  0.354
2008 Mattis VB, Butchbach ME, Lorson CL. Detection of human survival motor neuron (SMN) protein in mice containing the SMN2 transgene: applicability to preclinical therapy development for spinal muscular atrophy. Journal of Neuroscience Methods. 175: 36-43. PMID 18771690 DOI: 10.1016/J.Jneumeth.2008.07.024  0.326
2008 Thurmond J, Butchbach ME, Palomo M, Pease B, Rao M, Bedell L, Keyvan M, Pai G, Mishra R, Haraldsson M, Andresson T, Bragason G, Thosteinsdottir M, Bjornsson JM, Coovert DD, et al. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy. Journal of Medicinal Chemistry. 51: 449-69. PMID 18205293 DOI: 10.1021/jm061475p  0.311
2007 Gabanella F, Butchbach ME, Saieva L, Carissimi C, Burghes AH, Pellizzoni L. Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severity and preferentially affect a subset of spliceosomal snRNPs. Plos One. 2: e921. PMID 17895963 DOI: 10.1371/Journal.Pone.0000921  0.317
2007 Butchbach ME, Edwards JD, Burghes AH. Abnormal motor phenotype in the SMNDelta7 mouse model of spinal muscular atrophy. Neurobiology of Disease. 27: 207-19. PMID 17561409 DOI: 10.1016/j.nbd.2007.04.009  0.312
2007 Tian G, Lai L, Guo H, Lin Y, Butchbach ME, Chang Y, Lin CL. Translational control of glial glutamate transporter EAAT2 expression. The Journal of Biological Chemistry. 282: 1727-37. PMID 17138558 DOI: 10.1074/Jbc.M609822200  0.392
2005 Le TT, Pham LT, Butchbach ME, Zhang HL, Monani UR, Coovert DD, Gavrilina TO, Xing L, Bassell GJ, Burghes AH. SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Human Molecular Genetics. 14: 845-57. PMID 15703193 DOI: 10.1093/Hmg/Ddi078  0.357
2004 Butchbach ME, Tian G, Guo H, Lin CL. Association of excitatory amino acid transporters, especially EAAT2, with cholesterol-rich lipid raft microdomains: importance for excitatory amino acid transporter localization and function. The Journal of Biological Chemistry. 279: 34388-96. PMID 15187084 DOI: 10.1074/Jbc.M403938200  0.403
2003 Guo H, Lai L, Butchbach ME, Stockinger MP, Shan X, Bishop GA, Lin CL. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice. Human Molecular Genetics. 12: 2519-32. PMID 12915461 DOI: 10.1093/Hmg/Ddg267  0.43
2003 Butchbach ME, Guo H, Lin CL. Methyl-beta-cyclodextrin but not retinoic acid reduces EAAT3-mediated glutamate uptake and increases GTRAP3-18 expression. Journal of Neurochemistry. 84: 891-4. PMID 12562531 DOI: 10.1046/J.1471-4159.2003.01588.X  0.546
2002 Guo H, Lai L, Butchbach ME, Lin CL. Human glioma cells and undifferentiated primary astrocytes that express aberrant EAAT2 mRNA inhibit normal EAAT2 protein expression and prevent cell death. Molecular and Cellular Neurosciences. 21: 546-60. PMID 12504589 DOI: 10.1006/Mcne.2002.1198  0.518
2002 Butchbach ME, Lai L, Lin CL. Molecular cloning, gene structure, expression profile and functional characterization of the mouse glutamate transporter (EAAT3) interacting protein GTRAP3-18. Gene. 292: 81-90. PMID 12119102 DOI: 10.1016/S0378-1119(02)00669-8  0.503
Show low-probability matches.